eSMART: Randomised controlled trial to evaluate electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology for patients with cancers

Study code 
CTU-1
Disease 
Breast, Colorectal and Haematological Cancer
Recruitment 
Closed
Date 
01/09/2015
Status 
Analysis & Reporting
eSMART aims to demonstrate benefits for cancer patients using a real-time, mobile phone based remote patient monitoring system, the Advanced Symptom Management System (ASyMS). It is anticipated to greatly improve patient outcomes and delivery of care both during and after chemotherapy treatment.

The project will be conducted across 16 European sites with 1108 patients being recruited. Patients will be invited onto the trial, with eligibility determined by a) undergoing their first course of chemotherapy, b) for breast, colorectal or haematological cancers and c) planning to receive a minimum of 4 cycles of chemotherapy.
 

https://www.youtube.com/watch?v=F7iViTqSF5s&index=7&list=PLvpwIjZTs-LjHD...

 

Trim content